Articles related to ASPIRIN
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
In this pivotal trial, apixaban, when used for subclinical atrial fibrillation, demonstrated a 0.63 hazard ratio for stroke or systemic embolism compared to aspirin, indicating a significant reduction in stroke risk at the expense of increased bleeding risk.
Cardiology January 17th 2024
Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study
Recent research reveals aspirin’s significant impact on reducing cancer mortality and preventing metastatic spread, offering a promising addition to cancer therapy protocols.
Oncology, Medical January 16th 2024